Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan;165(1-2):28-35.
doi: 10.1007/s10354-014-0331-8. Epub 2015 Jan 21.

Efficacy and safety of rituximab in rheumatic diseases

Eva Rath  1 , Jochen Zwerina, Bastian Oppl, Valerie Nell-Duxneuner
Affiliations
Review

Efficacy and safety of rituximab in rheumatic diseases

Eva Rath et al. Wien Med Wochenschr. 2015 Jan.

Abstract

B-cell depleting therapy is now in clinical use for more than 10 years in rheumatology. In 2001, a first report was published on five rheumatoid arthritis patients responding to the chimeric anti-CD20 antibody rituximab. Since then, numerous clinical trials, prospective and retrospective studies, registry data as well as case reports on the use of rituximab in autoimmune rheumatic diseases have been published. This review gives a short overview on clinical data of rituximab in rheumatic diseases currently available.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ann Rheum Dis. 2012 Jan;71(1):84-7 - PubMed
    1. Ann Rheum Dis. 2013 Feb;72(2):308-10 - PubMed
    1. Arch Neurol. 2011 Sep;68(9):1156-64 - PubMed
    1. Ann Rheum Dis. 2010 Jan;69(1):193-7 - PubMed
    1. Case Rep Rheumatol. 2012;2012:406963 - PubMed

MeSH terms

LinkOut - more resources

  NODES
Note 1
twitter 2